Literature DB >> 21419678

Visual acuity through Bangerter filters in nonamblyopic eyes.

Robert P Rutstein1, Nicole C Foster, Susan A Cotter, Raymond T Kraker, Dave H Lee, Michele Melia, Graham E Quinn, Susanna M Tamkins, David K Wallace.   

Abstract

PURPOSE: To describe the amount of visual acuity degradation induced by Bangerter filters in the better seeing eye and to evaluate its stability over time in children with moderate amblyopia.
METHODS: Visual acuity with and without a Bangerter filter was measured in the nonamblyopic eye of 186 children with moderate amblyopia who were then treated with either patching or the Bangerter filters. A 0.2 filter was used for amblyopia of 20/80 and a 0.3 filter for amblyopia from 20/40 to 20/63. For the 89 children randomized to Bangerter filters, visual acuity was also measured in the nonamblyopic eye with and without the filters at both 6 weeks and 12 weeks after initiating treatment.
RESULTS: Mean degradation in visual acuity of the nonamblyopic eye at baseline was 5.1 logMAR lines with the 0.2 filter and 4.8 logMAR lines with the 0.3 filter. The degradation with each filter did not always agree with the manufacturer's specifications. Over time, the amount of degradation with the filters decreased.
CONCLUSIONS: The 0.2 and 0.3 Bangerter filters degrade nonamblyopic eye visual acuity sufficiently in amblyopic children. Because the amount of degradation decreases over time, it is recommended to periodically apply a new filter when using this type of amblyopia treatment.
Copyright © 2011 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21419678      PMCID: PMC3098928          DOI: 10.1016/j.jaapos.2010.11.015

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  12 in total

1.  The amblyopia treatment study visual acuity testing protocol.

Authors:  J M Holmes; R W Beck; M X Repka; D A Leske; R T Kraker; R C Blair; P S Moke; E E Birch; R A Saunders; R W Hertle; G E Quinn; K A Simons; J M Miller
Journal:  Arch Ophthalmol       Date:  2001-09

2.  Contrast sensitivity in amblyopia: the fellow eye of untreated and successfully treated amblyopes.

Authors:  Klio I Chatzistefanou; George P Theodossiadis; Alexandros G Damanakis; Ioannis D Ladas; Michalis N Moschos; Eleutheria Chimonidou
Journal:  J AAPOS       Date:  2005-10       Impact factor: 1.220

3.  Optical characterization of Bangerter foils.

Authors:  Guillermo M Pérez; Steven M Archer; Pablo Artal
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-30       Impact factor: 4.799

4.  Nonsurgical management of binocular diplopia induced by macular pathology.

Authors:  M Silverberg; E Schuler; S Veronneau-Troutman; K Wald; A Schlossman; N Medow
Journal:  Arch Ophthalmol       Date:  1999-07

5.  Bangerter foils in the treatment of moderate amblyopia.

Authors:  I L Iacobucci; S M Archer; B A Furr; E J Martonyi; M A Del Monte
Journal:  Am Orthopt J       Date:  2001

6.  A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children.

Authors:  Robert P Rutstein; Graham E Quinn; Elizabeth L Lazar; Roy W Beck; Dean J Bonsall; Susan A Cotter; Eric R Crouch; Jonathan M Holmes; Darren L Hoover; David A Leske; Ingryd J Lorenzana; Michael X Repka; Donny W Suh
Journal:  Ophthalmology       Date:  2010-02-16       Impact factor: 12.079

7.  The effect of induced monocular blur on measures of stereoacuity.

Authors:  Naomi V Odell; Sarah R Hatt; David A Leske; Wendy E Adams; Jonathan M Holmes
Journal:  J AAPOS       Date:  2008-12-13       Impact factor: 1.220

8.  Treatment of anisometropic amblyopia with spectacles or in combination with translucent Bangerter filters.

Authors:  Pia Agervi; Ulla Kugelberg; Maria Kugelberg; Gunnela Simonsson; Monica Fornander; Charlotta Zetterström
Journal:  Ophthalmology       Date:  2009-06-04       Impact factor: 12.079

9.  A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol.

Authors:  Roy W Beck; Pamela S Moke; Andrew H Turpin; Frederick L Ferris; John Paul SanGiovanni; Chris A Johnson; Eileen E Birch; Danielle L Chandler; Terry A Cox; R Clifford Blair; Raymond T Kraker
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

10.  Amblyopia: the normal eye is not normal.

Authors:  L E Leguire; G L Rogers; D L Bremer
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1990 Jan-Feb       Impact factor: 1.402

View more
  6 in total

Review 1.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

2.  The Test-Retest Variability of the COMPlog System in Participants with Induced Non-Normal Visual Acuity.

Authors:  Mun Wei Kan; Anne Bjerre
Journal:  Br Ir Orthopt J       Date:  2019-04-11

3.  The Amblyopia Treatment Studies: Implications for Clinical Practice.

Authors:  Angela M Chen; Susan A Cotter
Journal:  Adv Ophthalmol Optom       Date:  2016-08

4.  Portable acuity screening for any school: validation of patched HOTV with amblyopic patients and Bangerter normals.

Authors:  Maya Tsao Wu; M Diane Armitage; Claire Trujillo; Anna Trujillo; Laura E Arnold; Lauren Tsao Wu; Robert W Arnold
Journal:  BMC Ophthalmol       Date:  2017-12-04       Impact factor: 2.209

5.  Biological Action Identification Does Not Require Early Visual Input for Development.

Authors:  Siddhart S Rajendran; Davide Bottari; Idris Shareef; Kabilan Pitchaimuthu; Suddha Sourav; Nikolaus F Troje; Ramesh Kekunnaya; Brigitte Röder
Journal:  eNeuro       Date:  2020-10-28

6.  Effect of interocular differences on binocular visual performance after inducing forward scattering.

Authors:  Francesco Martino; José J Castro-Torres; Miriam Casares-López; Sonia Ortiz-Peregrina; Carolina Ortiz; José R Jiménez
Journal:  Ophthalmic Physiol Opt       Date:  2022-05-02       Impact factor: 3.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.